Max Healthcare Institute
BSE 543220 · ISIN INE027H01010
8 stories, newest first.
- Max Healthcare to hold Q2 & H1 FY27 earnings call for investors and analysts on November 3, 2026
- Board meeting on October 30, 2026 to consider and approve unaudited Q2 and H1 financial results
- Max Healthcare saw a short buildup in derivatives data amid continued focus on private hospital names
- Shareholders approve PRSU Scheme 2026, subsidiary grants and change in Main Objects Clause
- ESG rating of '66' assigned for financial year 2025-26
- CARE upgrades Crosslay Remedies (Max Healthcare unit) LT rating to CARE AA+/Stable; CARE A1+ reaffirmed
- CARE AA+/Stable reaffirmed on Rs.1,818.88 crore long-term bank facilities of Max Healthcare; CARE A1+ on Rs.80.00 crore short-term
- Max Healthcare stock fell for a fifth straight session with heavy volumes and high delivery percentage
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.